MITZI BRAY: Open Payments
NPI 1912266883 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 97 payments from 19 companies in 2025. Trend: 2023 $1,597 · 2024 $2,131 · 2025 $1,857
Food & beverage: $1,843Education: $13
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $264 |
| ABBVIE INC. | 13 | $225 |
| Arcutis Biotherapeutics, Inc. | 10 | $203 |
| Galderma Laboratories, L.P. | 9 | $155 |
| Incyte Corporation | 6 | $146 |
| LEO Pharma Inc. | 8 | $144 |
| Regeneron Healthcare Solutions, Inc. | 5 | $139 |
| PFIZER INC. | 5 | $86 |
| UCB, Inc. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
Products named: TREMFYA, Zoryve, DUPIXENT, RINVOQ, NEMLUVIO, OPZELURA, ADBRY, CIBINQO.
Industry payments across CA — which companies pay providers there.
